Call for Applications: Clinical Trials in Thalassemia Cell and Gene Therapy Grant Award
The purpose of this initiative is to speed the application of recent translational advances in gene therapy to clinical trials. The Foundation recognizes that there are many key areas worthy of support in the search for a cure for thalassemia with cell therapy and gene therapy. While several funding mechanisms are available for a range of studies on vector development, proof of concept studies in animal models, and transplantation, there remains a funding gap for launching human trials. Both phase I (safety) and phase II (efficacy) trials are eligible for support. Funding and candidate eligibil...
Source: ScanGrants feed - December 3, 2013 Category: Research Authors: Cooley’s Anemia Foundation Source Type: funding
NEI Translational Research Program (TRP) on therapy for Visual Disorders (R24)
Funding Opportunity Number: PAR-13-370 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: HealthCFDA Number: 93.867Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status with the IRS,...
Source: Grants.gov - September 30, 2013 Category: Research Tags: Health Source Type: funding
NEI Translational Research Program (TRP) on therapy for Visual Disorders (R24)
Funding Opportunity PAR-13-370 from the NIH Guide for Grants and Contracts. The National Eye Institute (NEI) announces the reissue of PAR-10-281, "Translational Research Program (TRP) on Therapy for Visual Disorders". This program focuses on the development of novel therapies to treat visual diseases and disorders. In the context of this program, an expert develops a multi-disciplinary research team that applies an integrative approach to develop rapid and efficient translation of innovative laboratory research findings into clinical therapeutic development. It involves collaborative teams of scientists and clinici...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 30, 2013 Category: Research Source Type: funding
Request for Proposals: Parkin Biology and Therapeutic Development Studies
The Michael J. Fox Foundation for Parkinson’s Research (MJFF) seeks to fund pre-clinical studies that investigate the biological function and therapeutic potential of Parkin protein. The ultimate goal is to identify therapeutic agents that alter the course of Parkinson’s disease. There will be two separate ‘Tracks’ that may be pursued for support around Parkin as follows: TRACK A – Biology TRACK B – Therapeutic Development Applicants may submit proposals to both Track A and Track B but it will need to do so by submitting separate applications that provide independent...
Source: ScanGrants feed - May 20, 2013 Category: Research Authors: Michael J. Fox Foundation for Parkinson’s Research Source Type: funding
Travel Fellowships for Nanotechnologies in Cancer Diagnosis, Therapy, and Prevention
June 11 - 13, 2013 Moscow, Russia World Trade Center Moscow Congress Center Presented by The New York Academy of Sciences, the Mushett Family Foundation, and the Skolkovo Institute of Science and Technology Poster Abstract Deadline: April 24, 2013 Harnessing principles from chemistry, biology, physics, and engineering, nanotechnology is a multidisciplinary field still in its infancy. Throughout the past decade, nanoparticles and specifically nanoparticle drug delivery systems, have emerged at the forefront of cancer therapies. Nanotechnology has helped to design and fabricate micro-scale devices, i...
Source: ScanGrants feed - February 11, 2013 Category: Research Authors: New York Academy of Sciences Source Type: funding
Call for Applications: Career Development Awards in Support of Research into Inherited Orphan Retinal Degenerative Diseases and Non-Exudative Age-Related Macular Degeneration
Application Deadline: March 15, 2013 The Foundation Fighting Blindness (FFB) is soliciting applications for Career Development Awards (CDA) from clinical research scientists of superior dedication and talent. The award is for junior investigators to pursue vigorous research programs to drive the research to find the therapies and cures for retinal degenerative diseases (RDDs), i.e., inherited orphan retinal degenerative diseases and non-exudative age-related macular degeneration. The goal of this Program is to facilitate advances in laboratory and clinical research, to elucidate the mechanisms for the etiology and...
Source: ScanGrants feed - January 28, 2013 Category: Research Authors: Foundation Fighting Blindness Source Type: funding
FacioScapuloHumeral Muscular Dystrophy Society Research Grants and Fellowships
The FSH Society offers basic research grants, research fellowships and postdoctoral fellowships to support research relevant to understanding the molecular genetics and cause of Facioscapulohumeral Muscular Dystrophy (FSHD). To obtain an application, please submit a letter of intent. The letter of intent should contain a single page introductory cover letter plus a one or two page descriptive summary of the proposed research – enough for a decision from the Scientific Advisory Board. A well conceived and tight rationale for a research project can easily lend itself to one page. The letter of intent may be su...
Source: ScanGrants feed - January 28, 2013 Category: Research Authors: FacioScapuloHumeral Muscular Dystrophy Society Source Type: funding
National Tay-Sachs & Allied Diseases Association Request for Proposals
National Tay-Sachs & Allied Diseases Association Request for Proposals The National Tay-Sachs & Allied Diseases Association Inc. (NTSAD) is considered to be the nation’s oldest genetic disease nonprofit organization. The “Allied Diseases” represent a family of almost 100 rare diseases including lysosomal storage diseases (LSD) and leukodystrophies affecting the central nervous system. A major element of NTSAD’s mission is to lead the fight to treat and cure Tay-Sachs, Canavan and related genetic diseases; therefore, NTSAD is committed to funding research projects that advance this missio...
Source: ScanGrants feed - January 3, 2013 Category: Research Authors: National Tay-Sachs & Allied Diseases Association Source Type: funding
